A 13-year-old African-American female taking sertraline for obsessive compu
lsive disorder was diagnosed with her first episode of atrioventricular (AV
) nodal re-entrant tachycardia five days after beginning Mixed Salts of a S
ingle-Entity Amphetamine Product (Adderall) for treatment of attention-defi
cit hyperactivity disorder (ADHD). She received successful cardioversion wi
th 6 mg of intravenous adenosine, but developed a second episode of possibl
e AV nodal re-entrant tachycardia twelve days after Adderall was reinitiate
d at half the previous dose. The patient had clinically similar cardiac epi
sodes five and six months after treatment was changed to slow-release methy
lphenidate, Stimulant medication may evoke onset of AV nodal tachyarrhythmi
as in patients who have the potential to develop them, possibly in combinat
ion with a selective serotonergic reuptake inhibitor (SSRI).